Figure 7.1. Median height z-scores for transplant patients <16 years in 2011
Centres with less than 50% data completeness were excluded from the
centre specific analysis but were included in the UK totals
UK Renal Registry 15th Annual Report
Figure 7.2. Median weight z-scores for transplant patients <16 years in 2011
UK Renal Registry 15th Annual Report
Figure 7.3. Median BMI z-scores for transplant patients <16 years in 2011
Centres with less than 50% data completeness were excluded from the centre
specific analysis but were included in the UK totals
UK Renal Registry 15th Annual Report
Figure 7.4. Median height z-scores for dialysis patients <16 years in 2011
Centres with less than 50% data completeness were excluded from the
centre specific analysis but were included in the UK totals
UK Renal Registry 15th Annual Report
Figure 7.5. Median weight z-scores for dialysis patients <16 years in 2011
UK Renal Registry 15th Annual Report
Figure 7.6. Median BMI z-scores for dialysis patients <16 years in 2011
Centres with less than 50% data completeness were excluded from the
centre specific analysis but were included in the UK totals
UK Renal Registry 15th Annual Report
Figure 7.7. Use of growth hormone in children <16 years with a height
under 2SD in the UK between 2001 and 2011
UK Renal Registry 15th Annual Report
Figure 7.8. Median systolic blood pressure z-scores for transplant patients
<16 years in 2011
UK Renal Registry 15th Annual Report
Figure 7.9. Median systolic blood pressure z-scores for dialysis patients
<16 years in 2011
Centres with less than 50% data completeness were excluded from the
centres specific analysis but were included in the UK totals
UK Renal Registry 15th Annual Report
Figure 7.10. The percentage of patients <16 years achieving the treatment
standard for haemoglobin between 2000–2011, by treatment modality
UK Renal Registry 15th Annual Report
Figure 7.11. The achievement of haemoglobin
treatment standards in paediatric transplant patients
<16 years, by the level of graft function
This figures combines all data from 2000–2011.
UK Renal Registry 15th Annual Report
Figure 7.12. The achievement of haemoglobin treatment standards in
paediatric transplant patients <16 years, by use of MMF between 2000–2011
UK Renal Registry 15th Annual Report
Figure 7.13. The use of erythropoietin and IV iron in paediatric patients
<16 years between 2001 and 2011 by treatment modality
UK Renal Registry 15th Annual Report